NVAX Q1 2026 Earnings NarrowerThanExpected Loss Beats Estimates Stock Edges Higher CR Q1 2026 Earnings EPS Surge Exceeds Expectations Shares Rise AES Q1 2026 Earnings EPS Surges 80 Above Estimates Powered by Strong Execution Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges CBOE Q1 2026 Earnings EPS Surges Past Estimates with 1028 Beat DXC Technology Q1 2026 Earnings EPS Beats Estimates Stock Rises 293